Condition
Hypokalemic Periodic Paralysis
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results67% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 2 (1)
P 3 (2)
Trial Status
Completed2
Terminated1
Not Yet Recruiting1
Recruiting1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07194174Not ApplicableRecruitingPrimary
Effect of Physical Training in Individuals With Hypokalemic and Hyperkalemic Periodic Paralysis
NCT06917430Not Yet Recruiting
Muscle MRI Outlining of Neuromuscular Diseases Using Artificial Intelligence
NCT02582476Phase 2TerminatedPrimary
Bumetanide in Hypokalaemic Periodic Paralysis
NCT00494507Phase 3Completed
Hyper- and Hypokalemic Periodic Paralysis Study
NCT00004802Phase 3Completed
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel Disorders
Showing all 5 trials